ERAS (STOCKS)
Erasca, Inc. Common Stock
$14.140000
+0.090000 (+0.64%)
Prev close: $14.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan E. Lim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,487.51M
- Employees
- 129
- P/E (TTM)
- -15.47
- P/B (TTM)
- 11.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.60 | $-0.21 | -0.3869 | -181.56% |
|
Dec 2025 (Q4)
|
$-0.10 | $-0.11 | +0.0091 | +8.34% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.11 | -0.0046 | -4.36% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.11 | -0.0078 | -6.95% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $16.17M |
| Operating Expenses | $293.19M |
| Operating Income/Loss | -$293.19M |
| Income/Loss From Continuing Operations After Tax | -$277.02M |
| Income/Loss From Continuing Operations Before Tax | -$277.02M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$277.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$277.02M |
| Net Income/Loss Available To Common Stockholders, Basic | -$277.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 871,454,383 |
| Diluted Average Shares | 871,454,383 |
| Assets | $461.23M |
| Current Assets | $253.78M |
| Cash | $408.50M |
| Noncurrent Assets | $207.45M |
| Fixed Assets | $12.61M |
| Other Non-current Assets | $194.84M |
| Liabilities | $67.71M |
| Current Liabilities | $26.66M |
| Accounts Payable | $2.16M |
| Other Current Liabilities | $24.50M |
| Noncurrent Liabilities | $41.04M |
| Equity | $393.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $393.53M |
| Liabilities And Equity | $461.23M |
| Net Cash Flow From Operating Activities | -$91.28M |
| Net Cash Flow From Operating Activities, Continuing | -$91.28M |
| Net Cash Flow From Investing Activities | -$177.67M |
| Net Cash Flow From Investing Activities, Continuing | -$177.67M |
| Net Cash Flow From Financing Activities | $245.73M |
| Net Cash Flow From Financing Activities, Continuing | $245.73M |
| Net Cash Flow | -$23.23M |
| Net Cash Flow, Continuing | -$23.23M |
| Comprehensive Income/Loss | -$278.13M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$278.35M |
| Other Comprehensive Income/Loss | -$31.73M |